Learning Objectives:

•Pre-TCR signaling is a new therapeutic opportunity for T-ALL
•Menin inhibition has activity against a previously uncharacterized subset of T-ALL cases
Session date: 
08/25/2025 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dr. Caner Saygin